Marker Therapeutics (MRKR) Other Gross PP&E Adjustments (2018 - 2023)
Marker Therapeutics (MRKR) has disclosed Other Gross PP&E Adjustments for 6 consecutive years, with -$525000.0 as the latest value for Q2 2023.
- Quarterly Other Gross PP&E Adjustments fell 106.7% to -$525000.0 in Q2 2023 from the year-ago period, while the trailing twelve-month figure was -$525000.0 through Mar 2024, down 104.42% year-over-year, with the annual reading at $11.6 million for FY2022, 8395.17% up from the prior year.
- Other Gross PP&E Adjustments for Q2 2023 was -$525000.0 at Marker Therapeutics, down from $11.9 million in the prior quarter.
- The five-year high for Other Gross PP&E Adjustments was $11.9 million in Q1 2023, with the low at -$14.4 million in Q4 2020.
- Average Other Gross PP&E Adjustments over 5 years is $653673.4, with a median of -$244568.0 recorded in 2019.
- The sharpest move saw Other Gross PP&E Adjustments tumbled 54752.59% in 2020, then skyrocketed 8395.17% in 2022.
- Over 5 years, Other Gross PP&E Adjustments stood at -$26174.0 in 2019, then crashed by 54752.59% to -$14.4 million in 2020, then soared by 100.95% to $136539.0 in 2021, then surged by 8395.17% to $11.6 million in 2022, then tumbled by 104.53% to -$525000.0 in 2023.
- According to Business Quant data, Other Gross PP&E Adjustments over the past three periods came in at -$525000.0, $11.9 million, and $11.6 million for Q2 2023, Q1 2023, and Q4 2022 respectively.